Sector Gamma ASA as of March 31, 2011
Portfolio Holdings for Sector Gamma ASA
Sector Gamma ASA holds 29 positions in its portfolio as reported in the March 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 9.4 | $42M | 120k | 351.70 | |
| Abbott Laboratories (ABT) | 9.3 | $42M | 85k | 490.51 | |
| Bristol Myers Squibb (BMY) | 7.4 | $33M | 126k | 264.30 | |
| Onyx Pharmaceuticals | 6.2 | $28M | 79k | 351.80 | |
| St. Jude Medical | 5.3 | $24M | 46k | 512.59 | |
| Forest Laboratories | 5.0 | $22M | 69k | 323.00 | |
| Medtronic | 4.9 | $22M | 56k | 393.50 | |
| Quest Diagnostics Incorporated (DGX) | 4.9 | $22M | 38k | 577.21 | |
| Cardinal Health (CAH) | 4.6 | $21M | 50k | 411.29 | |
| Watson Pharmaceuticals | 4.5 | $20M | 36k | 560.09 | |
| CVS Caremark Corporation (CVS) | 4.5 | $20M | 58k | 343.20 | |
| Life Technologies | 4.0 | $18M | 34k | 524.19 | |
| WellPoint | 3.9 | $17M | 25k | 697.91 | |
| C.R. Bard | 3.1 | $14M | 14k | 993.11 | |
| Merck & Co (MRK) | 2.9 | $13M | 39k | 330.10 | |
| Thermo Fisher Scientific (TMO) | 2.9 | $13M | 23k | 555.50 | |
| Zimmer Holdings (ZBH) | 2.5 | $11M | 19k | 605.29 | |
| Community Health Systems (CYH) | 2.2 | $10M | 25k | 399.92 | |
| Medco Health Solutions | 1.9 | $8.6M | 15k | 561.63 | |
| Cubist Pharmaceuticals | 1.9 | $8.5M | 34k | 252.39 | |
| Hologic (HOLX) | 1.8 | $7.9M | 36k | 222.01 | |
| Biogen Idec (BIIB) | 1.5 | $6.7M | 9.1k | 733.95 | |
| Thoratec Corporation | 1.0 | $4.6M | 18k | 259.31 | |
| Momenta Pharmaceuticals | 1.0 | $4.4M | 28k | 158.51 | |
| Boston Scientific Corporation (BSX) | 1.0 | $4.3M | 60k | 71.90 | |
| Teleflex Incorporated (TFX) | 0.9 | $4.1M | 7.1k | 579.86 | |
| ViroPharma Incorporated | 0.7 | $3.3M | 17k | 198.97 | |
| PSS World Medical | 0.6 | $2.9M | 11k | 271.52 | |
| WuXi PharmaTech | 0.3 | $1.5M | 9.6k | 154.61 |
